Cargando…

Rituximab Monotherapy versus Rituximab and Bortezomib Combination Therapy for Treatment of Non-paraneoplastic Autoimmune Retinopathy

PURPOSE: To study whether rituximab and bortezomib combination therapy is more effective than rituximab monotherapy in the treatment of non-paraneoplastic autoimmune retinopathy (npAIR). METHODS: Retrospective case series involving six patients with npAIR, taking either rituximab and bortezomib comb...

Descripción completa

Detalles Bibliográficos
Autores principales:	Maleki, Arash, Colombo, Amanda, Look-Why, Sydney, Peter Y Chang, BA;, Anesi, Stephen D
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	PUBLISHED BY KNOWLEDGE E 2022
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9806323/ https://www.ncbi.nlm.nih.gov/pubmed/36620716 http://dx.doi.org/10.18502/jovr.v17i4.12304

Ejemplares similares

Rituximab as a monotherapy or in combination therapy for the treatment of non-paraneoplastic autoimmune retinopathy
por: Maleki, Arash, et al.
Publicado: (2017)

Efficacy of rituximab in non-paraneoplastic autoimmune retinopathy
por: Boudreault, Katherine, et al.
Publicado: (2017)

A reverse translational study on the effect of rituximab, rituximab plus belimumab, or bortezomib on the humoral autoimmune response in SLE
por: van Dam, Laura S, et al.
Publicado: (2020)

COVID-19 Recombinant mRNA Vaccines and Serious Ocular Inflammatory Side Effects: Real or Coincidence?
por: Maleki, Arash, et al.
Publicado: (2021)

B-Scan Ultrasonography Findings in Unilateral Posterior Scleritis
por: Maleki, Arash, et al.
Publicado: (2022)

Bortezomib plus rituximab versus rituximab in patients with high-risk, relapsed, rituximab-naïve or rituximab-sensitive follicular lymphoma: subgroup analysis of a randomized phase 3 trial
por: Zinzani, Pier Luigi, et al.
Publicado: (2012)

Combination of low-dose rituximab, bortezomib and dexamethasone for the treatment of autoimmune hemolytic anemia
por: Yao, Mingkang, et al.
Publicado: (2022)

Paraneoplastic acute exudative polymorphous vitelliform maculopathy improved with intravitreal methotrexate
por: Gao, Jie, et al.
Publicado: (2020)

Bortezomib/ibrutinib/rituximab: Various toxicities: case report
Publicado: (2021)

Electroretinographic improvement after rituximab therapy in a patient with autoimmune retinopathy
por: Uludag, Gunay, et al.
Publicado: (2016)

Idiopathic Orbital Inflammation Treated With Rituximab Monotherapy
por: Bawazeer, Amani, et al.
Publicado: (2023)

Rituximab for autoimmune retinopathy: Results of a Phase I/II clinical trial
por: Armbrust, Karen R., et al.
Publicado: (2020)

Rituximab for Autoimmune Encephalitis with Epilepsy
por: Kurukumbi, Mohankumar, et al.
Publicado: (2020)

Severe Refractory Paraneoplastic Mucous Membrane Pemphigoid Successfully Treated With Rituximab
por: Wittenberg, Marcel, et al.
Publicado: (2019)

A rare case of MGRS with immunotactoid glomerulopathy responding to bortezomib, dexamethasone, and rituximab
por: Kuang, Chaoyuan, et al.
Publicado: (2020)

Use of Bortezomib in the Treatment of C3 Glomerulonephritis Refractory to Eculizumab and Rituximab
por: Hui, Jessica W., et al.
Publicado: (2020)

Rituximab for interstitial pneumonia with autoimmune features at two medical centres
por: D’Silva, Kristin M, et al.
Publicado: (2021)

Pharmacodynamics of rituximab on B lymphocytes in paediatric patients with autoimmune diseases
por: Pan, Shan, et al.
Publicado: (2019)

Rituximab Associated Hypogammaglobulinemia in Autoimmune Disease
por: Tieu, Joanna, et al.
Publicado: (2021)

Serum Autoantibody Profiling of Patients with Paraneoplastic and Non-Paraneoplastic Autoimmune Retinopathy
por: ten Berge, Josianne C., et al.
Publicado: (2016)

Multimodal imaging in non-paraneoplastic autoimmune retinopathy
por: Kasongole, David, et al.
Publicado: (2019)

Cold autoimmune hemolytic anemia resolved by rituximab
por: Palombi, Massimiliano, et al.
Publicado: (2010)

A Case of Autoimmune Hepatitis Treated with Rituximab
por: Barth, E., et al.
Publicado: (2010)

Reversing Autoimmunity Combination of Rituximab and Intravenous Immunoglobulin
por: Ahmed, A. Razzaque, et al.
Publicado: (2018)

Treatment of Refractory Pediatric Autoimmune Hepatitis With Rituximab
por: Saul, Samantha A., et al.
Publicado: (2021)

Rituximab monotherapy become an optimal treatment for primary pulmonary malt lymphoma
por: Alvarez-Sánchez, A.I., et al.
Publicado: (2018)

Paraneoplastic Pemphigus Associated with B-cell Chronic Lymphocytic Leukemia Treated with Ibrutinib and Rituximab
por: Ito, Yuta, et al.
Publicado: (2018)

Paraneoplastic acute fibrinous and organizing pneumonia from lymphoma completely responding to bendamustine‐rituximab
por: Crowhurst, Thomas, et al.
Publicado: (2020)

A Phased Desensitization Protocol With Rituximab and Bortezomib for Highly Sensitized Kidney Transplant Candidates
por: Ide, Kentaro, et al.
Publicado: (2015)

Copanlisib plus rituximab combination therapy vs. rituximab monotherapy for relapsed indolent non-Hodgkin lymphoma: a cost-effectiveness analysis
por: Tang, Xiao, et al.
Publicado: (2022)

Addition of rituximab in relapsed/refractory chronic lymphocytic leukemia after progression on venetoclax monotherapy
por: Handunnetti, Sasanka, et al.
Publicado: (2021)

Late-onset neutropenia after treatment with rituximab for rheumatoid arthritis and other autoimmune diseases: data from the AutoImmunity and Rituximab registry
por: Salmon, J H, et al.
Publicado: (2015)

Rituximab
por: Tridente, Giuseppe
Publicado: (2013)

Use of rituximab in paediatric nephrology
por: Sinha, Rajiv, et al.
Publicado: (2021)

Autoantibodies against retinal proteins in paraneoplastic and autoimmune retinopathy
por: Adamus, Grazyna, et al.
Publicado: (2004)

Intravenous Immunoglobulin for Management of Non-paraneoplastic Autoimmune Retinopathy
por: Fekri, Sahba, et al.
Publicado: (2020)

Structural and Functional Changes in Non-Paraneoplastic Autoimmune Retinopathy
por: Akhavanrezayat, Amir, et al.
Publicado: (2023)

Rituximab Monotherapy in the Management of a Rare Case of an HIV Associated Lymphoproliferative Disorder
por: Hew, Jason, et al.
Publicado: (2017)

Follicular Lymphomas of Oral Region Treated by Rituximab Monotherapy: About Two Cases
por: Montaner, Sylvain, et al.
Publicado: (2018)

Rituximab-associated Hypogammaglobulinemia in pediatric patients with autoimmune diseases
por: Khojah, Amer M., et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_m91c51jmf1kv8s5clgrtg0f6ln